AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 65(3), 2001, pp. 189-192
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, E
Right arrow Articles by Sadetzki, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, E
Right arrow Articles by Sadetzki, S
Related Collections
Right arrow Travel Medicine
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 65, Issue 3, 189-192
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Serious adverse events of mefloquine in relation to blood level and gender

E Schwartz, I Potasman, M Rotenberg, S Almog, and S Sadetzki

Mefloquine is widely used for prophylaxis in areas with chloroquine-resistant falciparum malaria. As the use of mefloquine has increased, so have the reports on its adverse effects. We sought to evaluate the possible association between serum levels of mefloquine and serious side effects caused by this drug by means of a case-control design study. The study population included 17 patients who presented to emergency rooms or travel clinics with symptoms suggesting serious adverse effects of mefloquine and 28 controls (healthy people, still taking mefloquine after travel). The mean age of the patients and the controls was 31.5 +/- 11.6 years and 34 +/- 12.2 years, respectively. The percentage of women among the patients was higher than in the control population (76% versus 40%, respectively; P = 0.03). Most of the complaints were related to the central nervous system (13 of 17); 5 patients interrupted their trip and 2 others were hospitalized. No difference in the level of mefloquine in the blood was found between the patients and the control groups. Also, no significant difference was found between mefloquine levels in the blood of men and women. These results suggest that blood levels of mefloquine do not correlate with its severe adverse events. Women tended to be more susceptible than men, despite having similar blood levels of the drug.


This article has been cited by other articles:


Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers
JAMA, May 23, 2007; 297(20): 2251 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
T. S. WELLS, T. C. SMITH, B. SMITH, L. Z. WANG, C. J. HANSEN, R. J. REED, W. E. GOLDFINGER, T. E. CORBEIL, C. N. SPOONER, and M. A.K. RYAN
Mefloquine use and hospitalizations among us service members, 2002-2004.
Am J Trop Med Hyg, May 1, 2006; 74(5): 744 - 749.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
E. Fiaccadori, U. Maggiore, C. Rotelli, R. Giacosa, E. Parenti, A. Cabassi, K. Ariya, and L. Wirote
Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine
J. Antimicrob. Chemother., January 1, 2006; 57(1): 160 - 161.
[Full Text] [PDF]

Home page
 QJMHome page
S. Ranque, B. Marchou, D. Malvy, E. Adehossi, R. Laganier, H. Tissot-Dupont, A. Lotte, S. Dydymsky, J. Durant, J.-P. Stahl, et al.
Treatment of imported malaria in adults: a multicentre study in France
QJM, October 1, 2005; 98(10): 737 - 743.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
J K Aronson and R E Ferner
Joining the DoTS: new approach to classifying adverse drug reactions
BMJ, November 22, 2003; 327(7425): 1222 - 1225.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.